Companies / BOC Sciences / Ruplizumab
BOC Sciences

Ruplizumab | BOC Sciences

Ruplizumab is a humanized monoclonal antibody directed against CD154. Ruplizumab has the potential for the treatment of rheumatic diseases.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.